The clinical utility of pharmacometric models.
作者信息
Kumar Shaun S, Biltaji Eman, Bies Robert, Sherwin Catherine M
机构信息
Division of Clinical Pharmacology, Department of Pediatrics, University of Utah, School of Medicine, Salt Lake City, UT, USA.
Department of Pharmacotherapy, College of Pharmacy, University of Utah, Salt Lake City, UT, USA.
出版信息
Br J Clin Pharmacol. 2018 Jul;84(7):1413-1414. doi: 10.1111/bcp.13603. Epub 2018 May 2.
Abstract
摘要
相似文献
1
The clinical utility of pharmacometric models.药代动力学模型的临床应用。
Br J Clin Pharmacol. 2018 Jul;84(7):1413-1414. doi: 10.1111/bcp.13603. Epub 2018 May 2.
2
A Perspective on Quantitative Systems Pharmacology Applications to Clinical Drug Development.定量系统药理学在临床药物研发中的应用展望
CPT Pharmacometrics Syst Pharmacol. 2020 Dec;9(12):675-677. doi: 10.1002/psp4.12567. Epub 2020 Nov 7.
3
Application of Pharmacometric Analysis in the Design of Clinical Pharmacology Studies for Biosimilar Development.药效学分析在生物类似药开发临床药理学研究设计中的应用。
AAPS J. 2018 Mar 7;20(2):40. doi: 10.1208/s12248-018-0196-7.
4
Linked Pharmacometric-Pharmacoeconomic Modeling and Simulation in Clinical Drug Development.临床药物研发中的药物代谢动力学-药物经济学建模与模拟的关联。
Clin Pharmacol Ther. 2021 Jul;110(1):49-63. doi: 10.1002/cpt.2051. Epub 2020 Oct 26.
5
Verifying and Validating Quantitative Systems Pharmacology and In Silico Models in Drug Development: Current Needs, Gaps, and Challenges.在药物研发中验证和确认定量系统药理学及计算机模拟模型：当前需求、差距与挑战
CPT Pharmacometrics Syst Pharmacol. 2020 Apr;9(4):195-197. doi: 10.1002/psp4.12504. Epub 2020 Apr 1.
6
Industry Perspective on Using MIDD for Pediatric Studies Requiring Integration of Ontogeny.行业视角：利用发育综合评估（MIDD）开展需要整合胚胎-胎儿发育的儿科研究
J Clin Pharmacol. 2019 Sep;59 Suppl 1:S112-S119. doi: 10.1002/jcph.1495.
7
Model-Informed Drug Development: Connecting the Dots With a Totality of Evidence Mindset to Advance Therapeutics.模型指导的药物研发：以全面证据思维连接各个环节以推进治疗学发展。
Clin Pharmacol Ther. 2021 Nov;110(5):1147-1154. doi: 10.1002/cpt.2422.
8
Welcome to the statistics and pharmacometrics themed issue.欢迎阅读本期统计与药代动力学主题专刊。
CPT Pharmacometrics Syst Pharmacol. 2021 Apr;10(4):273-274. doi: 10.1002/psp4.12625.
9
Clinical Studies for the Sake of Negative Data: The Proof Is in the Pudding.为获取阴性数据而开展的临床研究：实践出真知。
Clin Transl Sci. 2018 Nov;11(6):535-536. doi: 10.1111/cts.12568. Epub 2018 Jul 10.
10
Impact of pharmacokinetic-pharmacodynamic modelling in early clinical drug development.药代动力学-药效学模型在早期临床药物开发中的影响。
Eur J Pharm Sci. 2017 Nov 15;109S:S53-S58. doi: 10.1016/j.ejps.2017.05.042. Epub 2017 May 20.
引用本文的文献
1
The Utility of Pharmacometric Models in Clinical Pharmacology Research in Infants.药动学模型在婴儿临床药理学研究中的应用
Curr Pharmacol Rep. 2020 Oct;6(5):260-266. doi: 10.1007/s40495-020-00234-5. Epub 2020 Aug 18.
本文引用的文献
1
Predicting CYP3A-mediated midazolam metabolism in critically ill neonates, infants, children and adults with inflammation and organ failure.预测伴有炎症和器官衰竭的危重新生儿、婴儿、儿童和成人 CYP3A 介导的咪达唑仑代谢。
Br J Clin Pharmacol. 2018 Feb;84(2):358-368. doi: 10.1111/bcp.13459. Epub 2017 Nov 29.
2
Understanding and applying pharmacometric modelling and simulation in clinical practice and research.在临床实践和研究中理解并应用药代动力学建模与模拟。
Br J Clin Pharmacol. 2017 Feb;83(2):247-254. doi: 10.1111/bcp.13119. Epub 2016 Sep 29.
3
AUC-Guided Vancomycin Dosing in Adolescent Patients With Suspected Sepsis.AUC 指导下的疑似脓毒症青少年患者万古霉素给药方案
J Clin Pharmacol. 2017 Jan;57(1):77-84. doi: 10.1002/jcph.782. Epub 2016 Jul 15.
4
Inflammation and Organ Failure Severely Affect Midazolam Clearance in Critically Ill Children.炎症和器官衰竭严重影响危重症儿童咪达唑仑的清除率。
Am J Respir Crit Care Med. 2016 Jul 1;194(1):58-66. doi: 10.1164/rccm.201510-2114OC.
5
The pharmacokinetics of metformin and concentrations of haemoglobin A1C and lactate in Indigenous and non-Indigenous Australians with type 2 diabetes mellitus.二甲双胍的药代动力学以及澳大利亚原住民和非原住民2型糖尿病患者的糖化血红蛋白和乳酸浓度。
Br J Clin Pharmacol. 2015 Apr;79(4):617-23. doi: 10.1111/bcp.12525.
6
Population pharmacokinetics of metformin in healthy subjects and patients with type 2 diabetes mellitus: simulation of doses according to renal function.健康受试者和 2 型糖尿病患者中二甲双胍的群体药代动力学：根据肾功能模拟剂量。
Clin Pharmacokinet. 2013 May;52(5):373-84. doi: 10.1007/s40262-013-0046-9.
7
Effect of Australian elapid venoms on blood coagulation: Australian Snakebite Project (ASP-17).澳大利亚毒蛇毒液对凝血的影响：澳大利亚蛇伤项目（ASP-17）。
Toxicon. 2013 Jan;61:94-104. doi: 10.1016/j.toxicon.2012.11.001. Epub 2012 Nov 11.
8
Understanding the time course of pharmacological effect: a PKPD approach.理解药效的时间过程：一种 PKPD 方法。
Br J Clin Pharmacol. 2011 Jun;71(6):815-23. doi: 10.1111/j.1365-2125.2011.03925.x.
9
Clinical trial simulation: a review.临床试验模拟：综述。
Clin Pharmacol Ther. 2010 Aug;88(2):166-82. doi: 10.1038/clpt.2010.114. Epub 2010 Jul 7.
10
A comprehensive model for the humoral coagulation network in humans.人类体液凝血网络的综合模型。
Clin Pharmacol Ther. 2009 Sep;86(3):290-8. doi: 10.1038/clpt.2009.87. Epub 2009 Jun 10.
Zotero 插件